Michael R. Kozlowski
Michael R. Kozlowski publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Ophthalmology, on topics such as Neuroscience and Neuropharmacology Research, Retinal Diseases and Treatments and Receptor Mechanisms and Signaling.
- World rank
- #3,446,570 of 7,710,434 ranked researchers
- Rank in United States
- #966,890 of 1,627,098
- Works
- 63
- Citations
- 1.6k
- Citations per work
- 25.2
What does Michael R. Kozlowski research?
Michael R. Kozlowski's work is mostly in Medicine (26%), Biochemistry, Genetics and Molecular Biology (23%), Neuroscience (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2641.3%
- Life Sciences2133.0%
- Health Sciences1625.7%
- Medicine1625.7%
- 1Molecular Biology23% of their works
- 2Cellular and Molecular Neuroscience10% of their works
- 3Ophthalmology10% of their works
- 4Physiology8% of their works
- 5Pharmacology4% of their works
- 6Oncology4% of their works
Research topics
- Neuroscience and Neuropharmacology Research
- Retinal Diseases and Treatments
- Receptor Mechanisms and Signaling
- Retinal Development and Disorders
- Alzheimer's disease research and treatments
- Cholinesterase and Neurodegenerative Diseases
- Ion channel regulation and function
- Histone Deacetylase Inhibitors Research
Which keywords describe Michael R. Kozlowski's research?
The keywords of their largest research topics: Macular Degeneration, Oxidative Stress, Pharmacology, Cell Signaling, Diabetic Retinopathy, Neurotransmission, Retinal Pigment Epithelium and Synaptic Plasticity.
- Voltage-Gated Channels
- Histone Deacetylases
- Cholinesterase Inhibitors
- Tau Pathology
- Gene Therapy
- G-Protein-Coupled Receptors
- Synaptic Plasticity
- Neurotransmission
- Cell Signaling
- Oxidative Stress
- Macular Degeneration
- Pharmacology
- Diabetic Retinopathy
- Retinal Pigment Epithelium
- Crystal Structure
- Amyloid Hypothesis
- Retinitis Pigmentosa
- Acetylcholinesterase
- HDAC Inhibitors
- Ion Channels
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Macular Degeneration172 topics
- Oxidative Stress172 topics
- Pharmacology152 topics
- Cell Signaling122 topics
- Diabetic Retinopathy101 topic
- Neurotransmission101 topic
- Retinal Pigment Epithelium101 topic
- Synaptic Plasticity101 topic
- Crystal Structure91 topic
- G-Protein-Coupled Receptors91 topic
- Amyloid Hypothesis71 topic
- Gene Therapy71 topic
- Retinitis Pigmentosa71 topic
- Tau Pathology71 topic
- Acetylcholinesterase61 topic
- Cholinesterase Inhibitors61 topic
- HDAC Inhibitors31 topic
- Histone Deacetylases31 topic
- Ion Channels31 topic
- Voltage-Gated Channels31 topic
Where does Michael R. Kozlowski work?
Michael R. Kozlowski's main affiliation in the publication record is Midwestern University, United States.
How many publications and citations does Michael R. Kozlowski have?
OpenAlex counts 63 works and 1,585 citations for Michael R. Kozlowski, an h-index of 23, ranking #3,446,570 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael R. Kozlowski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.